News Image

Kalaris Expands Leadership Team Appointing Matthew Gall, MBA, as Chief Financial Officer

Provided By GlobeNewswire

Last update: Nov 3, 2025

Highly experienced biopharma financial officer joins leadership team 

CFO hire bolsters Kalaris’ leadership team and supports continued growth of the company as it enrolls its Phase 1b/2 study in treatment naïve nAMD patients

Read more at globenewswire.com

KALARIS THERAPEUTICS INC

NASDAQ:KLRS (12/19/2025, 4:09:50 PM)

After market: 9.1184 -0.01 (-0.13%)

9.13

-1.29 (-12.38%)



Find more stocks in the Stock Screener

KLRS Latest News and Analysis

Follow ChartMill for more